Table 2.
Distribution of study groups according to site, Bryne’s Grading, Primary Tumor Size, TNM staging
| Site | II | III | Total | Chi square | P value |
|---|---|---|---|---|---|
| ABC = 17 | ABC = 15 (50%) | 60 | 0.835 | 0.841# | |
| (56.6%) | BM = 5(16.6%) | ||||
| BM = 6(20%) | Lip = 2(6.6%) | ||||
| Lip = 1(3.3%) | Tongue = 8(26.6%) | ||||
| Tongue = 6(20%) | |||||
| Histopathological Diagnosis (Bryne’s grading) | WDSCC = 14 (46.6%) | WDSCC = 14 (46.6%) | 60 | 0.000 | 1.000# |
| MDSCC = 10 (33.3%) | MDSCC = 10 (33.3%) | ||||
| PDSCC = 6 (20%) | PDSCC = 6 (20%) | ||||
| Tumor Size | T1 = 12(40%) | T1 = 4 | 60 | 8.132 | 0.043* |
| T2 = 8(26.6%) | T2 = 6 | ||||
| T3 = 8(26.6%) | T3 = 18 | ||||
| T4a = 2(6.6%) | T4a = 2 | ||||
| TNM Staging | Stage I = 13 (43.3%) | Stage I = 0 | 60 | 17.875 | 0.000** |
| Stage II = 8 (26.6%) | Stage II = 0 | ||||
| Stage III = 7 (23.6%) | Stage III = 11 (36.6%) | ||||
| Stage IVa = 2 (6.6%) | Stage IVa = 19 (63.3%) |
Bold values represent total number of patients for ease of interpretation by the readers
ABC Alveolobuccal complex, BM Buccal mucosa, WDSCC Well differentiated squamous cell carcinoma, MDSCC Moderately differentiated squamous cell carcinoma, PDSCC Poorly differentiated squamous cell carcinoma, * = significant, ** = highly significant, # = non-significant